BlackRock Investment Management’s Pfizer PFE Stock Holding History

BlackRock Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$983M	Buy	31,909,848 +678,826	+2%	+$20.7M	1.14%	8
2016 Q3	$1B	Sell	31,231,022 -1,085,444	-3%	-$36.3M	1.23%	7
2016 Q2	$1.08B	Sell	32,316,466 -148,108	-0.5%	-$4.73M	1.37%	4
2016 Q1	$913M	Buy	32,464,574 +5,513,770	+20%	+$157M	1.19%	8
2015 Q4	$825M	Sell	26,950,804 -815,745	-3%	-$25.7M	1.06%	10
2015 Q3	$827M	Sell	27,766,549 -79,967	-0.3%	-$2.56M	1.12%	9
2015 Q2	$886M	Buy	27,846,516 +528,676	+2%	+$17.2M	1.1%	8
2015 Q1	$902M	Buy	27,317,840 +47,859	+0.2%	+$1.52M	1.18%	6
2014 Q4	$806M	Sell	27,269,981 -108,554	-0.4%	-$3.11M	1.07%	7
2014 Q3	$768M	Sell	27,378,535 -1,265,626	-4%	-$35.5M	1.07%	7
2014 Q2	$807M	Buy	28,644,161 +146,147	+0.5%	+$4.17M	1.08%	7
2014 Q1	$868M	Buy	28,498,014 +1,060,609	+4%	+$31.6M	1.26%	6
2013 Q4	$797M	Sell	27,437,405 -439,485	-2%	-$12.8M	1.18%	7
2013 Q3	$760M	Sell	27,876,890 -624,400	-2%	-$17M	1.25%	7
2013 Q2	$757M	Buy	+28,501,290	New	+$787M	1.35%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock Investment Management's PFE Position: Q4 2016 in Review

BlackRock Investment Management increased its Pfizer (PFE) stake by 2.2% in Q4 2016, buying an estimated $20.7M and bringing the position to 31,909,848 shares worth $983M. The position accounts for 1.14% of the portfolio, ranked #8.

BlackRock Investment Management first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.08B in Q2 2016. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

BlackRock Investment Management held 31,909,848 shares of Pfizer worth $983M as of Q4 2016.
BlackRock Investment Management bought 678,826 Pfizer shares in Q4 2016, an estimated $20.7M.
Pfizer made up 1.14% of BlackRock Investment Management's portfolio in Q4 2016, its #8 holding.
BlackRock Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Pfizer position peaked at $1.08B in Q2 2016.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.